copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
BIOTEST We would like to show you a description here but the site won’t allow us
Company Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine Biotest develops, manufactures and markets plasma proteins and biotherapeutic drugs Our value chain extends from pre-clinical and clinical development to worldwide marketing and distribution
Grifols completes the acquisition of Biotest: a strategic and . . . The acquisition of Biotest AG enables Grifols to accelerate and expand its product portfolio, increase the availability of plasma therapies for patients, own the largest private European network of plasma centers with 87 centers, and drive revenue growth and margin expansion
Biotest Acquisition: Key Details, Impact, and What Comes Next Founded in 1946, Biotest AG specializes in hematology, clinical immunology, and intensive care medicine Its core products include treatments for severe bacterial infections, coagulation disorders, and immune deficiencies, such as Pentaglobin, Haemoctin, and Intratect
Biotest | definition of biotest by Medical dictionary Determination of the potency or concentration of a compound by its effect on animals, isolated tissues, or microorganisms, as contrasted with analysis of its chemical or physical properties Synonym (s): biologic assay, biotest
Biotest wins FDA approval for plasma protein therapy Biotest, a subsidiary of Grifols, announced that the US FDA granted approval for its plasma protein therapy Yimmugo earlier today (17 June) Yimmugo is an intravenous immunoglobulin therapy developed as a substitution therapy for primary antibody deficiency syndromes
Grifols announces its investment in Biotest Biotest is a German public listed healthcare company specialized in innovative hematology and clinical immunology with an attractive pipeline with novel proteins that complement Grifols’ product portfolio
Biotest Biotest is a global company that supplies plasma protein products and biotherapeutic drugs Our products are primarily used in the therapeutic areas of clinical immunology, haematology and intensive care medicine
Biotest Biotest has a complete product line of infectious disease tests for over 32 infectious diseases, including SARS-CoV-2, HIV, HBV, HCV, HEV, SYP, Malaria, Dengue, Influenza A+B, etc